Literature DB >> 17180256

Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy.

Morten T Eriksen1, Arne Wibe, Jon Haffner, Johan N Wiig.   

Abstract

PURPOSE: The use of preoperative radiotherapy in patients with T3 tumors shows considerable variation among countries and institutions. The Norwegian guidelines have been very restrictive, limiting the indication to T4. This study was designed to identify subgroups of patients with T3 tumors with presumed high risks on adverse outcome and to use these results to reevaluate the national guidelines for preoperative radiotherapy.
METHODS: This was a national cohort study of 2,460 patients with pT3 rectal adenocarcinoma, undergoing major surgery without preoperative radiotherapy from November 1993 to December 2002. Circumferential resection margin in millimeters was given for 1,676 patients.
RESULTS: Multivariate analyses identified circumferential resection margin and nodal status as independent prognostic factors for local recurrence, metastases, and overall mortality. Analyses based on 12 combinations of N stage and circumferential resection margin showed that the estimated five-year rate of local recurrence increased from 11.1 percent (circumferential resection margin >3 mm; N0) to 36.5 percent (circumferential resection margin < or =1 mm; N2). The rate of distant metastases increased from 18.5 to 77.7 percent and the five-year survival decreased from 68.6 to 25.7 percent, respectively.
CONCLUSIONS: There is great variation in outcome for patients with T3 cancers, and the outcome is not acceptable for the groups of patients with circumferential resection margin <3 mm or involved lymph nodes. These groups should be considered for neoadjuvant therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17180256     DOI: 10.1007/s10350-006-0757-1

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  19 in total

1.  The influence of endorectal filling on rectal cancer staging with MRI.

Authors:  Rutger Ch Stijns; Tom Wj Scheenen; Johannes Hw de Wilt; Jurgen J Fütterer; Regina Gh Beets-Tan
Journal:  Br J Radiol       Date:  2018-06-14       Impact factor: 3.039

2.  Comparison of treatment results between surgery alone, preoperative short-course radiotherapy, or long-course concurrent chemoradiotherapy in locally advanced rectal cancer.

Authors:  Chung-Hung Yeh; Miao-Fen Chen; Chia-Hsuan Lai; Wen-Shih Huang; Steve P Lee; Wen-Cheng Chen
Journal:  Int J Clin Oncol       Date:  2011-09-22       Impact factor: 3.402

3.  Abdominoperineal resection and low anterior resection: comparison of long-term oncologic outcome in matched patients with lower rectal cancer.

Authors:  Jin C Kim; Chang S Yu; Seok B Lim; Chan W Kim; Jong H Kim; Tae W Kim
Journal:  Int J Colorectal Dis       Date:  2012-10-02       Impact factor: 2.571

4.  [The selective waiving of neoadjuvant (chemo)radiotherapy for rectal cancer lacks evidence].

Authors:  D Habermehl
Journal:  Chirurg       Date:  2016-10       Impact factor: 0.955

5.  [Even guidelines must be allowed to be questioned].

Authors:  Y Kulu; T Hackert; J Debus; M-A Weber; M W Büchler; A Ulrich
Journal:  Chirurg       Date:  2016-10       Impact factor: 0.955

6.  Neoadjuvant chemo-radiotherapy for cT3N0 rectal cancer: any benefit over upfront surgery? A propensity score-matched study.

Authors:  Luca Sorrentino; Marcello Guaglio; Luigi Battaglia; Giuliano Bonfanti; Marco Vitellaro; Alessandro Cesa Bianchi; Massimo Milione; Filiberto Belli
Journal:  Int J Colorectal Dis       Date:  2019-11-18       Impact factor: 2.571

7.  Regional lymph node metastasis and locoregional recurrence of rectal carcinoma in the era of TME [corrected] surgery. Implications for treatment decisions.

Authors:  Paul Hermanek; Susanne Merkel; Rainer Fietkau; Claus Rödel; Werner Hohenberger
Journal:  Int J Colorectal Dis       Date:  2009-12-10       Impact factor: 2.571

Review 8.  Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer--a review focusing on open questions.

Authors:  Lutz Moser; Jörg-Peter Ritz; Wolfgang Hinkelbein; Stefan Höcht
Journal:  Int J Colorectal Dis       Date:  2007-12-07       Impact factor: 2.571

9.  Outcome of patients with clinical stage II or III rectal cancer treated without adjuvant radiotherapy.

Authors:  Shin Fujita; Seiichiro Yamamoto; Takayuki Akasu; Yoshihiro Moriya
Journal:  Int J Colorectal Dis       Date:  2008-07-02       Impact factor: 2.571

Review 10.  Surgical treatment for rectal cancer: an international perspective on what the medical gastroenterologist needs to know.

Authors:  Rolv-Ole Lindsetmo; Yong-Geul Joh; Conor-P Delaney
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.